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SUMMARY 
A renal toxicity of 4 h inhalation exposure to I,l-dichloroethylene (vinylidene chloride; VDC) was 
studied in male Sprague-Dawley rats. Kidney wt./body wt. ratios, serum urea nitrogen and creatinine 
levels were significantly increased 24 h after exposure to 250 ppm or more of VDC. Histopathologic ex- 
amination by light microscopy of hematoxyhn and eosin (H&E)-stained sections revealed severe tubular 
necrosis with calcium deposits at the higher exposure concentrations. Specific staining for calcium ox- 
alate was negative, indicating that biotransformation of VDC to oxalate is probably not responsible for 
its nephrotoxicity. Pretreatment with polychlorinated biphenyl (PCB) induced the level of renal 
cytochrome P-450. Phenobarbital (PBT) pretreatment did not alter the renal P-450 level, but both PCB 
and PBT pretreatments antagonized VDC nephrotoxicity. These pretreatments have also been reported 
to antagonize VDC-induced hepatotoxicity. In summary, inhalation of VDC is nephrotoxic in the rat; 
the mechanism of nephrotoxicity does not involve calcium oxalate formation, and the magnitude of 
nephrotoxicity does not correlate directly with the total amount of renal cytochrome P-450. 
INTRODUCTION 
VDC is primarily used in the production of methyl chloroform and thermoplastic 
polymers [l]. VDC has been identified as a contaminant not only in the workplace 
but also in the closed environments of nuclear submarines and of spacecraft [2]. 
Although the hepatotoxicity of VDC has been extensively studied [3] there is little 
information concerning its nephrotoxic effects. Chronic exposure to VDC has been 
reported to result in kidney and liver injury in a variety of test species [4,5]. Jenkins 
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and Andersen [6] examined the acute nephrotoxicity of VDC in the rat following 
oral administration. They observed increases in plasma urea nitrogen, plasma 
creatinine and kidney weights, which were potentiated by fasting for 18 h im- 
mediately before VDC administration [6]. Fasting depletes glutathione (GSH) stores 
[7] and, since activated intermediates of VDC are detoxified by GSH [8], this deple- 
tion may be responsible for the observed potentiation of VDC nephrotoxicity. 
Jenkins and Andersen [6] also reported the occurrence of blue-black amorphous 
deposits, resembling calcium deposits, in H&E-stained necrotic renal tubules follow- 
ing VDC administration. Oxalic acid has been identified in small amounts in the 
urine of rats exposed to VDC [9]. Calcium oxalate is a potent nephrotoxicant [lo] 
but there have to date been no reports of investigations which specifically addressed 
the possibility that VDC nephrotoxicity is due to the formation of calcium oxalate. 
Alteration of the oxidative metabolism of VDC with inducers and inhibitors of 
cytochrome P-450 is known to affect VDC hepatotoxicity [ll]. Masuda and 
Nakayama [12] have shown in mice that carbon disulfide inhibits hepatic and renal 
microsomal drug-metabolizing enzyme activities and protects against renal and 
hepatic injury caused by VDC. 
These reports and our interest in mechanisms of VDC toxicity lead us to the 
studies of VDC nephrotoxicity reported here. Rats were exposed to VDC by inhala- 
tion. A concentration-response curve was obtained. The role of calcium oxalate for- 
mation and the effects of PBT and PCB pretreatments were examined. 
METHODS 
Inhalation exposures 
Inhalation exposures were performed in 30-l glass and stainless steel dynamic 
chambers. 4-6 Rats were used per chamber. VDC (MEHQ-inhibited, donated by 
Dow Chemical Co., Midland, MI) was volatilized in a gas washing bottle by a 
metered air flow. Total chamber air flow was maintained at 20 l/min. The actual 
VDC concentration was monitored by FID gas chromatography. Chamber air 
samples were taken at 15min intervals with a gas-tight syringe and injected into a 
Varian 940 gas chromatograph with a columnof 10% Carbowax 6000 on Diatoport 
S 60/80 mesh. All exposures were for 4 h, and began between 10:00 and 12:00 a.m. 
Animals and pretreatments 
Male Sprague-Dawley rats (225-275 g) were housed in pairs in suspended cages, 
over pine chip bedding, on a 12-h light-dark cycle. Food and water were supplied 
ad lib. For the pretreatment studies, rats received either 60 mg/kg/day sodium PBT 
(30 mg/ml in water) by gavage for 4 days, or 100 mg/kg/day PCB (Aroclor 1254, 
50 mg/ml in corn oil) by gavage for 3 days. VDC exposure was on the day following 
the last pretreatment. All rats were fasted for 18 h prior to exposure and received 
no food or water during exposure. Rats were allowed food and water after exposure. 
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Killing was by decapitation and exsanguination 24 h after the start of VDC ex- 
posure. For P-450 determinations, killing was 24 h after the last PCB or PBT 
pretreatment, allowing us to estimate the P-450 level that pretreated rats had during 
VDC exposure. 
Biochemical assays 
Serum urea nitrogen (mg urea nitrogen/100 ml serum) was measured by the 
urease method [ 131. The picric acid method was used to determine serum creatinine 
concentrations (mg creatinine/ 100 ml serum) [ 131. Kidneys were excised and weigh- 
ed for the determination of kidney wt./100 g body wt. ratios. 
Cytochrome P-4.50 assay 
Rats were killed 24 h after the last PBT or PCB pretreatment and after 18 h 
fasting. Livers and kidneys were removed and microsomes prepared according to 
the method of Omura and Sato [14]. Protein content was determined by the Biuret 
method [ 151. The microsomal samples were diluted to 1 mg protein/ml for liver and 
to 2 mg protein/ml for kidney. The carbon monoxide difference spectrum of reduc- 
ed cytochrome P-450 was measured using an Aminco DW-2-UV-visible 
spectrophotometer. 
Statistical analyses 
Dose-response data were analyzed by l-factor analysis of variance [ 161 and the 
effects of PCB and PBT pretreatment on cytochrome P-450 levels by 2-factor 
analysis of variance [16]. Multipie comparisons by the method of Bonferroni were 
used to establish the significance of differences at individual exposure levels 
(P<O.OS). Student’s t-test was used to compare individual means when applicable. 
Histopathology 
Slices of tissue were fixed in neutral buffered formalin. Fixed tissues were in- 
filtrated, embedded in paraffin, and sectioned. Six-micron-thick sections were stain- 
ed with either H&E [17] or silver nitrate-safranin. The von Kossa method [ 181 was 
used to stain for total calcium and the Pizzalato method [IO] was used for the 
specific determination of calcium oxalate. 
RESULTS AND DISCUSSION 
Kidney wt./body wt. ratios, serum urea nitrogen, and serum creatinine 
measurements were increased 24 h after exposure to VDC concentrations of 250 
ppm or greater (Table I). Some lethality also occurred in each exposure group at 
200 ppm or more (Table I). We think that the apparent decrease in nephrotoxicity 
at 400 ppm VDC may be due to more susceptible, and consequently more severely 
affected, animals dying before the scheduled killing. 
Fig. I. Hisropathological assessment of the effects of vinylidene chloride on the renal cortico-medullary 
junction (hematoxylin and eosin, magnification x 140). (a) Control; fb) 250 ppm VDC, 4 h exposure. 
Note vacuoiated tubule celis in the cortex; (c) 300 ppm VDC, 4 h exposure. Note necrosis of tubules and 
dark staining deposits in tubule cells (arrows); (d) 400 ppm YDC, 4 h exposure. Note massive necrosis 
of tubules and dark-staining deposits (arrows). 
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TABLE I 
EFFECT OF VDC EXPOSURE CONCENTRATION ON PARAMETERS OF NEPHROTOXICITY 
VDC Mortalityb Kidney wt./body wt. Serum urea nitrogen Serum creatinine 
concentration” (g/loo g) (mg/lOO ml) (mg/lOO ml) 
(ppm) 
0 o/22 0.88 + 0.04 8.3 f 0.4 0.66 * 0.02 
200 l/4 0.97 * 0.06 11.0 * 0.2 0.78 + 0.05 
250 l/l6 1.42 f 0.09* 29.8 rt 5.2* 1.51 f 0.17* 
300 3114 1.49 f O.O@ 41.8 It 5.0* 1.99 f 0.2s 
375 3/12 1.40 r 0.13* 33.2 z!z 7.5* 1.55 * 0.39* 
400 316 1.49 f 0.20* 22.8 f 9.1* 1.15 zt 0.32* 
Male Sprague-Dawley rats were killed 24 h after the start of a 4-h inhalation exposure to various concen- 
trations of VDC. Data are expressed as mean f SEM. 
a Actual chamber concentration varied by less than 5% of nominal concentration during exposure. 
’ Mortality data are presented as no. dead before sacrifice/total no. exposed). 
* Significantly different from control (PGO.05) by one-factor analysis of variance with multiple com- 
parisons by the method of Bonferroni. 
VDC exposure also caused histopathological changes in the kidney. For reference, 
a section from a control kidney is shown in Fig. la. A typical section prepared after 
exposure to 250 ppm VDC for 4 h shows only moderate cellular swelling in the renal 
cortex (Fig. lb). Exposure to higher concentrations of VDC (> 300 ppm) resulted 
in dark-staining deposits, resembling calcium salts, within the tubule cells (Fig. lc), 
and in severe cortical tubular necrosis (Fig. Id). 
Since oxalate is a urinary metabolite of VDC 191, the possibility that calcium ox- 
alate is the cause of VDC-induced nephrotoxicity was examined. Sections of renal 
tissue containing blue-black deposits after hematoxylin and eosin staining were 
analyzed for birefringence by light microscopy using a polarizing filter. No birefrin- 
gence was seen. Under identical conditions, actual calcium oxalate crystals stained 
with hematoxylin and eosin and were clearly birefringent. Staining for total calcium 
by the von Kossa silver nitrate method [16] demonstrated that the blue-black 
deposits were in fact calcium salts. Similar sections were treated with 2N acetic acid 
to remove calcium phosphate and calcium carbonate salts [lo]. Any remaining 
deposits that stain with silver nitrate must be calcium oxalate. No such silver nitrate- 
stained deposits were found. These results indicate that calcium oxalate does not 
constitute a major portion of the calcium deposits in the kidney following VDC 
exposure. 
Pretreatment with PBT or PCB had the expected effects [19,20] on rat liver 
hepatic and renal microsomal cytochrome-P-450 (Table II). In the liver, PBT and 
PCB caused 2-fold and 3-fold increases, respectively, in the level of cytochrome 
P-450. PBT did not significantly alter renal cytochrome P-450, whereas PCB 
resulted in 2-fold induction. Despite this difference in hepatic and renal cytochrome 
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TABLE II 
EFFECT OF PBT AND PCB PRETREATMENTS ON CYTOCHROME P-450 CONTENT 
Pretreatment Liver= Kidneya 
None 100 f 5.5 100 f 13 
PBT 210 * 9* 131 * 21 
PCB 296 + 4* 223 f 38; 
Rats were pretreated with PBT or Aroclor 1254 (PCB) and microsomal cytochrome P-450 content was 
measured as described in METHODS. 
a Data in PBT and PCB-pretreated groups are expressed as % of non-pretreated control t SEM. Na4. 
For liver, control = 0.787 + 0.021 nmol P-450/mg microsomal protein; for kidney, control = 0.1 IO 
+ 0.015 nmol P-450/mg microsomal protein. 
* Significantly greater than control (P60.05) by Student’s f-test. 
P-450 induction, both pretreatments were equally effective in reducing VDC-related 
nephrotoxicity (Table II). These effects of PCB and PBT pretreatment on VDC 
nephrotoxicity parallels that shown previously for VDC hepatotoxicity [ 1 l] and is 
consistent with several different possible mechanisms: (a) PBT and PCB may in- 
crease hepatic metabolism of VDC causing reduced circulating VDC concentrations 
and correspondingly reduced accumulation of toxic metabolites in the kidney; (b) 
although PBT did not significantly induce total renal P-450 (Table II), levels of the 
P-450 isozyme(s) primarily responsible for VDC detoxification [21] may be increas- 
ed; (c) PBT and PCB alter the activities of other enzyme systems, including 
glutathione S-transferase [22,23]. Since glutathione S-transferase is important for 
the detoxification of VDC [7], its induction by PBT and PCB could explain their 
antagonism of VDC nephrotoxicity. 
TABLE 111 
EFFECT OF PRETREATMENT WITH PBT OR PCB ON THE NEPHROTOXICITY OF VDC 
Pretreatment N VDC Kidney wt./ 
concentration body wt. 
(ppm) (g/l00 g) 
Serum urea nitrogen Serum creatinine 
(mg/lOO ml) (mg/lOO ml) 
None 22 None 0.88 + 0.04 8.3 + 0.4 0.66 f 0.02 
None 11 300 1.49 + 0.08** 41.8 + 5.0** 1.99 f 0.25** 
PBT 6 None 0.81 + 0.01 7.6 + 0.4 0.89 + 0.03 
PBT 5 300 0.91 + 0.03* 11.5 + 0.7* 0.90 f 0.02* 
FCB 4 None 1.04 + 0.05 9.1 + 0.05 0.53 + 0.01 
PCB 6 300 0.99 * 0.05* 8.2 + 0.3* 0.69 f 0.04* 
Male Sprague-Dawley rats were pretreated and exposed as described in Methods. Data are expressed as 
mean + standard error. 
** Significantly greater than not exposed, identically pretreated control PSO.05 by 2-factor ANOVA 
with multiple comparisons by the method of Scheffe. 
* Significantly less than not pretreated, similarly exposed group. PgO.05 by 2-factor ANOVA with 
multiple comparisons by the method of Scheffe. 
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In summary, these studies show that VDC is acutely nephrotoxic in the rat after 
inhalation exposure. VDC nephrotoxicity does not appear to be due to the 
biotransformation of VDC to calcium oxaIate. The similar effects of PBT and PCB 
pretreatments on both the hepatotoxicity and nephrotoxicity of VDC are consistent 
with a common mechanism of action of VDC on both of these target organs. The 
antagonism of VDC nephrotoxicity by PBT shows that the magnitude of this 
nephrotoxicity is not strictly correlated with the overall Ievel of renal P-450. 
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